Résumé Contexte Le Réseau canadien pour les traitements de l'humeur et de l'anxiété
(CANMAT) a publié les dernières lignes directrices cliniques pour le traitement du trouble …

Introduction Mental health disorders, especially depressive and anxiety disorders, are
associated with substantial health-related burden. While the second-generation …

In clinical practice, theta burst stimulation (TBS) presents as a more efficient and potentially
more effective therapeutic modality than conventional repetitive transcranial magnetic …

Introduction Depression is one of the most common psychological disorders in later life.
Although psychological interventions are recommended by treatment guidelines, most older …

Estimating the appropriate duration of antidepressant management following remission of
depression is clinically useful, and can be accomplished through random assignment of …

Methods Five databases were searched until September 2023 for relevant randomized
clinical trials evaluating the efficacy and safety of zuranolone. The potential risk of bias in the …

Objective There is growing evidence that adding non-steroidal anti-inflammatory drugs to
some psychopharmacological treatments may help to improve symptoms in patients …

The authors hypothesized that early relapse (eg, within 2–3 weeks or 1 month after
antidepressant discontinuation) in placebo recipients might represent antidepressant …

Both pooled PDE5-Is and individual PDE5-Is (sildenafil and vardenafil) outperformed the
placebo in the improvement of all IIEF domain scores. A recent meta-analysis recommended …

Since selective serotonin reuptake inhibitors were introduced in clinical practice in the
1990s, antidepressant prescriptions have steadily increased. In addition to the prescriptions …